How is Smith-Lemli-Opitz Syndrome diagnosed?

TL;DR: Smith-Lemli-Opitz syndrome is primarily diagnosed through biochemical testing that identifies elevated levels of 7-dehydrocholesterol (7-DHC) in the blood, often followed by confirmatory DHCR7 gene sequencing. This diagnosis is typically reached by clinical geneticists after observing a combination of characteristic physical features, developmental delays, and multisystem health issues.

How is Smith-Lemli-Opitz syndrome diagnosed step-by-step?

The diagnostic process for Smith-Lemli-Opitz syndrome (SLOS) usually begins when a pediatrician or specialist notices a constellation of symptoms, such as syndactyly (webbed toes), microcephaly, or specific facial features. Because SLOS is a metabolic disorder caused by a defect in cholesterol synthesis, the first step is almost always a plasma sterol analysis. This blood test measures the concentration of 7-dehydrocholesterol; an elevated level is a hallmark indicator of the condition. If the biochemical test is positive, clinicians will order molecular genetic testing to identify pathogenic variants in the DHCR7 gene, which confirms the diagnosis and helps in understanding the severity of the mutation.

What are the key clinical indicators and tests?

Diagnosis relies on a mix of clinical observation and laboratory confirmation. Medical professionals look for the following indicators:

• Biochemical markers: Significantly high 7-DHC levels and low total cholesterol levels in the blood.


• Physical examination: Identification of characteristic features such as ptosis (drooping eyelids), a small jaw, and second-third toe syndactyly.


• Genetic testing: Sequencing of the DHCR7 gene to identify the specific biallelic mutations responsible for the enzyme deficiency.


• Imaging: Brain MRIs or echocardiograms may be performed to assess the extent of developmental anomalies often associated with Smith-Lemli-Opitz syndrome.

Which specialists are involved in the diagnostic journey?

The "diagnostic odyssey" for patients with Smith-Lemli-Opitz syndrome can be long and frustrating, often spanning months or years as families visit multiple specialists. If your primary care provider is unfamiliar with the condition, it is vital to seek a referral to a clinical geneticist or a metabolic specialist. These experts are best equipped to interpret the complex biochemical results and provide the necessary genetic counseling. Within our community at DiseaseMaps.org, 61 people have shared their experiences, many noting that early consultation with a genetic center significantly shortened their path to an accurate diagnosis.

What conditions can be confused with Smith-Lemli-Opitz syndrome?

Because Smith-Lemli-Opitz syndrome presents with a wide spectrum of symptoms, it can be misdiagnosed or confused with other conditions. Differential diagnoses often include fetal alcohol spectrum disorders, Cornelia de Lange syndrome, or other malformation syndromes involving multiple organ systems. If a child shows failure to thrive combined with specific physical anomalies, it is crucial that Smith-Lemli-Opitz syndrome is ruled out early via metabolic screening to prevent unnecessary testing for other rarer conditions.

Why is early diagnosis important?

Receiving a definitive diagnosis for Smith-Lemli-Opitz syndrome is a critical turning point. It allows for the immediate initiation of cholesterol supplementation therapy and the management of specific health risks, such as photosensitivity and gastrointestinal issues. We understand the emotional toll of the diagnostic search; please know that identifying the root cause is the first step toward accessing tailored care and connecting with a community that understands your journey.

Next steps

• Consult a board-certified clinical geneticist to request a plasma sterol analysis.


• Request a referral to a metabolic clinic if Smith-Lemli-Opitz syndrome is suspected.


• Connect with the DiseaseMaps.org community to share experiences with others managing this condition.


• Maintain a detailed medical binder of all test results to streamline consultations with new specialists.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Smith-Lemli-Opitz syndrome overview.


• Orphanet: Rare Disease Database (ORPHA:3161).


• OMIM (Online Mendelian Inheritance in Man): Entry #270400 (DHCR7 gene).


• Smith-Lemli-Opitz Foundation: Patient and family support resources.